Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 1Brain Neoplasms 1

Interventions

Radiosurgery 11Temozolomide 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Nivolumab 4Mental Status and Dementia Tests 4Receptors, Interleukin-8B 3Memantine 3Ipilimumab 3trastuzumab deruxtecan 2pembrolizumab 2Surveys and Questionnaires 2sotorasib 1sapanisertib 1sacituzumab govitecan 1pertuzumab 1patritumab deruxtecan 1nabiximols 1fluciclovine F-18 1entrectinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1brodalumab 1auricularum 1abemaciclib 1Watchful Waiting 1Vorinostat 1Vitamin B 6 1Valacyclovir 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Valacyclovir × 30 days × Clear all
NCT06914479 2026-05-27

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
11 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡